This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

AOP: 659

Title

A descriptive phrase which references both the Molecular Initiating Event and Adverse Outcome.It should take the form “MIE leading to AO”. For example, “Aromatase inhibition leading to reproductive dysfunction” where Aromatase inhibition is the MIE and reproductive dysfunction the AO. In cases where the MIE is unknown or undefined, the earliest known KE in the chain (i.e., furthest upstream) should be used in lieu of the MIE and it should be made clear that the stated event is a KE and not the MIE.  More help

Renal tubular epithelial injury leading to renal interstitial fibrosis via maladaptive repair

Short name
A name that succinctly summarises the information from the title. This name should not exceed 90 characters. More help
Renal tubular injury to fibrosis via maladaptive repair
The current version of the Developer's Handbook will be automatically populated into the Handbook Version field when a new AOP page is created.Authors have the option to switch to a newer (but not older) Handbook version any time thereafter. More help
Handbook Version v2.8

Graphical Representation

A graphical representation of the AOP.This graphic should list all KEs in sequence, including the MIE (if known) and AO, and the pair-wise relationships (links or KERs) between those KEs. More help
Click to download graphical representation template Explore AOP in a Third Party Tool

Authors

The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. More help

Kohei Matsushita

National Institute of Health Sciences, Japan

Point of Contact

The user responsible for managing the AOP entry in the AOP-KB and controlling write access to the page by defining the contributors as described in the next section.   More help
Kohei Matsushita   (email point of contact)

Contributors

Users with write access to the AOP page.  Entries in this field are controlled by the Point of Contact. More help
  • Kohei Matsushita

Coaches

This field is used to identify coaches who supported the development of the AOP.Each coach selected must be a registered author. More help

OECD Information Table

Provides users with information concerning how actively the AOP page is being developed and whether it is part of the OECD Workplan and has been reviewed and/or endorsed. OECD Project: Assigned upon acceptance onto OECD workplan. This project ID is managed and updated (if needed) by the OECD. OECD Status: For AOPs included on the OECD workplan, ‘OECD status’ tracks the level of review/endorsement of the AOP . This designation is managed and updated by the OECD. Journal-format Article: The OECD is developing co-operation with Scientific Journals for the review and publication of AOPs, via the signature of a Memorandum of Understanding. When the scientific review of an AOP is conducted by these Journals, the journal review panel will review the content of the Wiki. In addition, the Journal may ask the AOP authors to develop a separate manuscript (i.e. Journal Format Article) using a format determined by the Journal for Journal publication. In that case, the journal review panel will be required to review both the Wiki content and the Journal Format Article. The Journal will publish the AOP reviewed through the Journal Format Article. OECD iLibrary published version: OECD iLibrary is the online library of the OECD. The version of the AOP that is published there has been endorsed by the OECD. The purpose of publication on iLibrary is to provide a stable version over time, i.e. the version which has been reviewed and revised based on the outcome of the review. AOPs are viewed as living documents and may continue to evolve on the AOP-Wiki after their OECD endorsement and publication.   More help
OECD Project # OECD Status Reviewer's Reports Journal-format Article OECD iLibrary Published Version
This AOP was last modified on November 09, 2026 02:37

Revision dates for related pages

Page Revision Date/Time
Increase, kidney fibrosis February 27, 2026 04:34
Increase, tubular epithelial cells exhibiting a failed-repair phenotype November 09, 2026 01:27
Increase, renal tubular epithelial cell injury November 09, 2026 02:57
Increase, renal tubular epithelial injury leads to Increase, failed-repair tubular epithelial cells November 09, 2026 02:20
Increase, failed-repair tubular epithelial cells leads to Increase, kidney fibrosis November 09, 2026 02:21

Abstract

A concise and informative summation of the AOP under development that can stand-alone from the AOP page. The aim is to capture the highlights of the AOP and its potential scientific and regulatory relevance. More help

Renal interstitial fibrosis is a major pathological consequence of persistent or incompletely resolved renal tubular injury and is an important outcome in the assessment of nephrotoxic substances. Although renal tubular epithelial cells possess substantial regenerative capacity, some injured cells fail to restore their normal differentiated phenotype and instead undergo maladaptive repair. This adverse outcome pathway (AOP) describes a proposed sequence of biological events linking renal tubular epithelial injury to renal interstitial fibrosis through the persistence of tubular epithelial cells exhibiting a failed-repair phenotype. The molecular initiating event is not specified, as multiple nephrotoxic stressors may converge on tubular epithelial injury.

The proposed pathway involves renal tubular epithelial injury, an increase in tubular epithelial cells exhibiting a failed-repair phenotype, and subsequent renal interstitial fibrosis as the adverse outcome (AO). Failed-repair tubular epithelial cells, particularly those originating from the proximal tubule, may exhibit persistent alterations in differentiation status and proinflammatory and profibrotic signaling. Persistent signaling from maladaptively repaired tubular epithelial cells may contribute to interstitial inflammation, fibroblast activation, and extracellular matrix accumulation.

Evidence from experimental kidney injury models, histopathological studies, and single-cell and single-nucleus transcriptomic analyses supports the association between failed tubular repair and renal fibrosis. Although substantial evidence supports a role for maladaptive tubular repair in renal fibrosis, the quantitative relationships between key events and the extent to which this pathway applies across different nephrotoxic stressors remain to be fully characterized. This AOP aims to provide a mechanistic framework for organizing existing evidence and identifying measurable endpoints relevant to the assessment of chemical-induced renal fibrosis.

AOP Development Strategy

Context

Used to provide background information for AOP reviewers and users that is considered helpful in understanding the biology underlying the AOP and the motivation for its development.The background should NOT provide an overview of the AOP, its KEs or KERs, which are captured in more detail below. More help

Renal interstitial fibrosis is an important histopathological outcome in the assessment of nephrotoxic substances. Although renal tubular epithelial cells have substantial regenerative capacity, recovery from tubular injury does not always result in restoration of normal epithelial structure and function. Understanding why some injured tubular epithelial cells undergo successful repair whereas others persist in an abnormal state is an important challenge in renal toxicology.

This AOP is being developed to organize and integrate mechanistic evidence concerning maladaptive renal tubular epithelial repair and its contribution to renal interstitial fibrosis. Particular emphasis is placed on the proximal tubule, which is a major target of nephrotoxic substances. Rather than focusing on a specific chemical or molecular initiating event, the AOP aims to provide a framework applicable to renal tubular injury induced by different nephrotoxic mechanisms.

This AOP is intended to provide a framework for organizing and evaluating measurable biological events associated with maladaptive tubular repair and for interpreting renal toxicity findings from a mechanistic perspective. Such a framework may also contribute to the development and evaluation of in vitro renal toxicity models and integrated approaches to chemical safety assessment.

Strategy

Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components.  Suggested content includes a rationale for and description of the scope and focus of the data search and identification strategy/ies including the nature of preliminary scoping and/or expert input, the overall literature screening strategy and more focused literature surveys to identify additional information (including e.g., key search terms, databases and time period searched, any tools used). More help

The development of this AOP follows an iterative, evidence-based approach, focusing on the biological events linking renal tubular epithelial injury to renal interstitial fibrosis through maladaptive tubular repair.

Starting from renal interstitial fibrosis as the defined adverse outcome, the development of this AOP focuses specifically on the upstream biological events associated with maladaptive repair following renal tubular epithelial injury. Relevant evidence is being identified through targeted literature searches using PubMed and examination of existing AOPs, key events (KEs), and key event relationships (KERs) in the AOP-Wiki. Search terms include combinations of "renal fibrosis," "tubular injury," "maladaptive repair," "failed-repair tubular epithelial cells," "proximal tubule," and "nephrotoxicity." Relevant references cited in review articles and primary research publications are also considered.

The evidence assessment focuses primarily on experimental kidney injury models, including chemically induced nephrotoxicity, and incorporates findings from histopathological, molecular, and single-cell or single-nucleus transcriptomic studies. Particular attention is given to the temporal sequence of biological events, their biological plausibility, and experimental evidence supporting causal relationships. Studies involving experimental interventions that modify tubular repair and assess the corresponding effects on subsequent fibrotic responses are considered particularly informative for evaluating KE essentiality.

KEs are selected based on their biological significance, measurability, and relevance to the progression toward renal fibrosis. Existing KEs and KERs in the AOP-Wiki are preferentially reused where their definitions are appropriate. Additional KEs are considered when necessary to represent important biological changes not adequately captured by existing entries. Detailed molecular mechanisms are incorporated into KER descriptions where appropriate, rather than being represented as separate KEs unless they constitute distinct and measurable events.

The strength of evidence supporting each KER will be evaluated based on biological plausibility, empirical support, and available quantitative information. Evidence gaps, uncertainties, and potential differences among nephrotoxic stressors will be documented as the AOP is developed.

Summary of the AOP

This section is for information that describes the overall AOP.The information described in section 1 is entered on the upper portion of an AOP page within the AOP-Wiki. This is where some background information may be provided, the structure of the AOP is described, and the KEs and KERs are listed. More help

Events:

Molecular Initiating Events (MIE)
An MIE is a specialised KE that represents the beginning (point of interaction between a prototypical stressor and the biological system) of an AOP. More help
Key Events (KE)
A measurable event within a specific biological level of organisation. More help
Adverse Outcomes (AO)
An AO is a specialized KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help
Type Event ID Title Short name
KE 2465 Increase, renal tubular epithelial cell injury Increase, renal tubular epithelial injury
KE 2464 Increase, tubular epithelial cells exhibiting a failed-repair phenotype Increase, failed-repair tubular epithelial cells
AO 2404 Increase, kidney fibrosis Increase, kidney fibrosis

Relationships Between Two Key Events (Including MIEs and AOs)

This table summarizes all of the KERs of the AOP and is populated in the AOP-Wiki as KERs are added to the AOP.Each table entry acts as a link to the individual KER description page. More help
Title Adjacency Evidence Quantitative Understanding

Network View

This network graphic is automatically generated based on the information provided in the MIE(s), KEs, AO(s), KERs and Weight of Evidence (WoE) summary tables. The width of the edges representing the KERs is determined by its WoE confidence level, with thicker lines representing higher degrees of confidence. This network view also shows which KEs are shared with other AOPs. More help

Prototypical Stressors

A structured data field that can be used to identify one or more “prototypical” stressors that act through this AOP. Prototypical stressors are stressors for which responses at multiple key events have been well documented. More help

Life Stage Applicability

The life stage for which the AOP is known to be applicable. More help

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available. More help

Sex Applicability

The sex for which the AOP is known to be applicable. More help

Overall Assessment of the AOP

Addressess the relevant biological domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and Weight of Evidence (WoE) for the overall AOP as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). More help

Domain of Applicability

Addressess the relevant biological domain(s) of applicability in terms of sex, life-stage, taxa, and other aspects of biological context. More help

Essentiality of the Key Events

The essentiality of KEs can only be assessed relative to the impact of manipulation of a given KE (e.g., experimentally blocking or exacerbating the event) on the downstream sequence of KEs defined for the AOP. Consequently, evidence supporting essentiality is assembled on the AOP page, rather than on the independent KE pages that are meant to stand-alone as modular units without reference to other KEs in the sequence. The nature of experimental evidence that is relevant to assessing essentiality relates to the impact on downstream KEs and the AO if upstream KEs are prevented or modified. This includes: Direct evidence: directly measured experimental support that blocking or preventing a KE prevents or impacts downstream KEs in the pathway in the expected fashion. Indirect evidence: evidence that modulation or attenuation in the magnitude of impact on a specific KE (increased effect or decreased effect) is associated with corresponding changes (increases or decreases) in the magnitude or frequency of one or more downstream KEs. More help

Evidence Assessment

Addressess the biological plausibility, empirical support, and quantitative understanding from each KER in an AOP. More help

Known Modulating Factors

Modulating factors (MFs) may alter the shape of the response-response function that describes the quantitative relationship between two KES, thus having an impact on the progression of the pathway or the severity of the AO.The evidence supporting the influence of various modulating factors is assembled within the individual KERs. More help
Modulating Factor (MF) Influence or Outcome KER(s) involved
     

Quantitative Understanding

Optional field to provide quantitative weight of evidence descriptors.  More help

Considerations for Potential Applications of the AOP (optional)

Addressess potential applications of an AOP to support regulatory decision-making.This may include, for example, possible utility for test guideline development or refinement, development of integrated testing and assessment approaches, development of (Q)SARs / or chemical profilers to facilitate the grouping of chemicals for subsequent read-across, screening level hazard assessments or even risk assessment. More help

References

List of the literature that was cited for this AOP. More help